Recordati reported EUR201.58M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
GlaxoSmithKline GBP 2.19B 75M Jun/2026
Hikma Pharmaceutical USD 288M 149M Dec/2025
Orion EUR 98.9M 7M Jun/2026
Sanofi EUR 2.63B 307M Jun/2026